Kaixin Holdings, a Hong Kong-based investment company, has experienced significant market volatility and recent developments, including a notable transaction involving its pharmaceutical subsidiary.
Kaixin Holdings’ market performance has been marked by significant volatility, with a rollercoaster ride of highs and lows, as the company navigates challenges and uncertainties in the Consumer Discretionary sector.